Rxivist logo

ZFP36 RNA-binding proteins restrain T-cell activation and anti-viral immunity

By Michael J Moore, Nathalie E Blachere, John J Fak, Christopher Y. Park, Kirsty Sawicka, Salina Parveen, Ilana Zucker-Scharff, Bruno Moltedo, Alexander Y. Rudensky, Robert B. Darnell

Posted 14 Jan 2018
bioRxiv DOI: 10.1101/247668 (published DOI: 10.7554/elife.33057)

Dynamic post-transcriptional control of RNA expression by RNA-binding proteins (RBPs) is critical during immune response. ZFP36 RBPs are prominent inflammatory regulators linked to autoimmunity and cancer, but functions in adaptive immunity are less clear. We used HITS-CLIP to define ZFP36 targets in T-cells, which revealed unanticipated actions in regulating T-cell activation, proliferation, and effector functions. Transcriptome and ribosome profiling showed that ZFP36 represses mRNA target abundance and translation, notably through a novel class of AU-rich sites in coding sequence. Functional studies revealed that ZFP36 regulates early T-cell activation kinetics in a cell autonomous manner, by attenuating activation marker expression, limiting T-cell expansion, and promoting apoptosis. Strikingly, loss of ZFP36 in vivo accelerated T-cell responses to acute viral infection, and enhanced anti-viral immunity. These findings uncover a critical role for ZFP36 RBPs in restraining T-cell expansion and effector functions, and suggest ZFP36 inhibition as a novel strategy to enhance immune-based therapies.

Download data

  • Downloaded 726 times
  • Download rankings, all-time:
    • Site-wide: 47,502
    • In molecular biology: 1,326
  • Year to date:
    • Site-wide: 46,007
  • Since beginning of last month:
    • Site-wide: 154,768

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide